Celsis International plc is a leading international provider of innovative life science products and laboratory services to the pharmaceutical and consumer products industries through our three divisions: Rapid Detection, Analytical Services and In Vitro Technologies. Now headquartered in Chicago USA, Celsis was founded in Cambridge, England UK and is listed on the London Stock Exchange CEL.L. Each Celsis division delivers substantial time and cost savings to customers whilst ensuring product quality and safety for consumers. Celsis Rapid Detection division is the world leader in rapid microbial methods RMM. Utilizing proprietary enzyme technology, we develop and supply screening systems instruments, software, reagents and services for the rapid detection of microbial contamination in pharmaceutical and consumer products. Our rapid testing systems provide significant economic value by reducing the time it takes companies to test and release their raw materials, inprocess goods and finished products to market.

Telephone: 1 312 476 1200
Website: http://www.celsis.com/